Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency

CD Platt, F Zaman, W Bainter, K Stafstrom… - Journal of Allergy and …, 2021 - Elsevier
Background Next-generation sequencing has become a first-line tool for the diagnosis of
primary immunodeficiency. However, patient access remains limited because of restricted …

Rapid molecular diagnostics of severe primary immunodeficiency determined by using targeted next-generation sequencing

H Yu, VW Zhang, A Stray-Pedersen, IC Hanson… - Journal of Allergy and …, 2016 - Elsevier
Background Primary immunodeficiency diseases (PIDDs) are inherited disorders of the
immune system. The most severe form, severe combined immunodeficiency (SCID) …

[HTML][HTML] Added value of reanalysis of whole exome-and whole genome sequencing data from patients suspected of primary immune deficiency using an extended …

SB Mørup, L Nazaryan-Petersen, M Gabrielaite… - Frontiers in …, 2022 - frontiersin.org
Background Knowledge of the genetic variation underlying Primary Immune Deficiency
(PID) is increasing. Reanalysis of genome-wide sequencing data from undiagnosed patients …

A 2020 update on the use of genetic testing for patients with primary immunodeficiency

IK Chinn, JS Orange - Expert Review of Clinical Immunology, 2020 - Taylor & Francis
Introduction Genetic testing of patients with clinically diagnosed or suspected primary
immunodeficiencies (PIDs) constitutes standard of care. Choice of testing modality and …

Diagnostic yield and therapeutic consequences of targeted next-generation sequencing in sporadic primary immunodeficiency

G Sogkas, N Dubrowinskaja, K Schütz… - … Archives of Allergy and …, 2022 - karger.com
Abstract Introduction: Primary immunodeficiencies (PIDs) are a heterogeneous group of
disorders characterized by increased susceptibility to infections, immune dysregulation …

[HTML][HTML] Next-generation sequencing in the field of primary immunodeficiencies: current yield, challenges, and future perspectives

EE Vorsteveld, A Hoischen, CI van der Made - Clinical reviews in allergy & …, 2021 - Springer
Primary immunodeficiencies comprise a group of inborn errors of immunity that display
significant clinical and genetic heterogeneity. Next-generation sequencing techniques and …

[HTML][HTML] Expanding the clinical and genetic spectra of primary immunodeficiency-related disorders with clinical exome sequencing: expected and unexpected findings

F Rudilla, C Franco-Jarava, M Martínez-Gallo… - Frontiers in …, 2019 - frontiersin.org
Primary immunodeficiencies (PIDs) refer to a clinically, immunologically, and genetically
heterogeneous group of over 350 disorders affecting development or function of the immune …

Unbiased targeted next-generation sequencing molecular approach for primary immunodeficiency diseases

H Al-Mousa, M Abouelhoda, DM Monies… - Journal of Allergy and …, 2016 - Elsevier
Background Molecular genetics techniques are an essential diagnostic tool for primary
immunodeficiency diseases (PIDs). The use of next-generation sequencing (NGS) provides …

[HTML][HTML] Clinical utility of whole exome sequencing and targeted panels for the identification of inborn errors of immunity in a resource-constrained setting

C Engelbrecht, M Urban, M Schoeman… - Frontiers in …, 2021 - frontiersin.org
Primary immunodeficiency disorders (PIDs) are inborn errors of immunity (IEI) that cause
immune system impairment. To date, more than 400 single-gene IEI have been well defined …

[HTML][HTML] Exome sequencing in routine diagnostics: a generic test for 254 patients with primary immunodeficiencies

P Arts, A Simons, MS AlZahrani, E Yilmaz, E AlIdrissi… - Genome Medicine, 2019 - Springer
Background Diagnosis of primary immunodeficiencies (PIDs) is complex and cumbersome
yet important for the clinical management of the disease. Exome sequencing may provide a …